KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Total Liabilities (2016 - 2026)

Colgate Palmolive has reported Total Liabilities over the past 18 years, most recently at $16.1 billion for Q1 2026.

  • For Q1 2026, Total Liabilities rose 1.32% year-over-year to $16.1 billion; the TTM value through Mar 2026 reached $16.1 billion, up 1.32%, while the annual FY2025 figure was $16.0 billion, 2.99% up from the prior year.
  • Total Liabilities for Q1 2026 was $16.1 billion at Colgate Palmolive, up from $16.0 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $16.4 billion in Q2 2025 and troughed at $14.9 billion in Q4 2022.
  • A 5-year average of $15.7 billion and a median of $15.9 billion in 2023 define the central range for Total Liabilities.
  • On a YoY basis, Total Liabilities climbed as much as 6.08% in 2022 and fell as far as 0.94% in 2022.
  • Year by year, Total Liabilities stood at $14.9 billion in 2022, then grew by 3.42% to $15.4 billion in 2023, then rose by 0.43% to $15.5 billion in 2024, then rose by 2.99% to $16.0 billion in 2025, then rose by 1.0% to $16.1 billion in 2026.
  • Business Quant data shows Total Liabilities for CL at $16.1 billion in Q1 2026, $16.0 billion in Q4 2025, and $16.3 billion in Q3 2025.